We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinoma.AuthorsOcean AJ; Polite B; Christos P; Horvath L; Hamilton A; Matulich D; Chen HX; Sparano JA; Kindler HLPublicationClinical colorectal cancer, 2010, Vol 9, Issue 5, p290ISSN1938-0674Publication typearticleDOI10.3816/CCC.2010.n.042